Nucleic acid amplification testing of deep tracheal aspirate for influenza A and B viruses, respiratory syncytial virus, and SARS-CoV-2 was negative. Cytomegalovirus DNA viral load was undetectable.

FDA Approves Merck’s Enflonsia for RSV Prevention in Infants: Enflonsia (clesrovimab-cfor) is a long-acting monoclonal antibody approved to prevent respiratory syncytial virus (RSV) lower respiratory ...

Test positivity for common cold coronaviruses significantly declined following widespread SARS-CoV-2 infection and COVID-19 ...

Expanded Approval: Moderna’s mRESVIA vaccine is now FDA-approved for adults aged 18–59 years with an increased risk for respiratory syncytial virus (RSV)-related lower respiratory tract disease.

A new national guideline provides evidence-based recommendations for diagnosing, treating, and preventing pediatric ...

The rapid identification of respiratory virus outbreaks is needed to enable rational and effective public health interventions. We developed new quantitative approaches for simultaneous ...

The United States could soon have another tool in the fight against respiratory syncytial virus, an illness that’s the No. 1 cause of hospitalization in infants.

A rare cell in the lining of lungs is fundamental to the organ-wide response necessary to repair damage from toxins like ...

Foot-and-mouth disease virus: an important virus in livestock For two of the four viruses (chikungunya and coxsackievirus A6), there was a slight drop in yield at higher temperatures.

Researchers in Japan have successfully generated lung cells similar to alveolar epithelial type 2 (AT2) cells from mouse ...